Amgen Inc.

Stocks

AMGN

US0311621009

Market Closed - Nasdaq Other stock markets 21:00:00 20/07/2026 BST			Pre-market 14:28:30
364.17 ^USD	-0.58%		363.80	-0.10%

07-20	Goldman Sachs Adjusts Price Target on Amgen to $427 From $425, Maintains Buy Rating	MT
07-16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE

Transcript : Amgen Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 09

Published on 06/04/2026 at 04:35 pm BST - Modified on 06/04/2026 at 06:05 pm BST

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Akash Tewari (Analysts)

Good morning, everyone. I hope you're doing well. Really pleased to see a packed room and really that goes for right now and also just the entire conference. My

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Amgen Inc.

07-20	Goldman Sachs Adjusts Price Target on Amgen to $427 From $425, Maintains Buy Rating	MT
07-16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE
07-13	BofA Securities Adjusts Amgen Price Target to $312 From $307	MT
07-13	UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating	MT
07-08	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says	MT
07-08	Morgan Stanley Adjusts Price Target Amgen to $333 From $340, Maintains Equalweight Rating	MT
07-07	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
07-07	Truist Securities Adjusts Amgen Price Target to $340 From $327	MT
07-06	Rothschild & Co Redburn Adjusts Price Target on Amgen to $220 From $200	MT
07-03	Amgen Inc. Announces Product Recall	CI
07-03	Amgen, Inc. Announces Product Recall	CI
07-03	Amgen Inc Recalls Sensipar Tablets 30 mg, 30-Count Bottles Due to CGMP Deviations	CI
07-03	Amgen Inc Announces Product Recall	CI
07-03	Amgen Recalls Corlanor Tablets Due to Presence of Foreign Substance	CI
07-02	Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug	MT